Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533227) titled 'Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia' on April 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Hua Jiang

Condition: Cachexia Cancer Fecal Microbiota Transplantation (FMT)

Intervention: Drug: FMT capsule

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: May 1, 2026

Target Sample Size: 66

To know more, visit https://clinicaltrials.gov/study/NCT07533227

Disclaimer: Curated by HT Syndication....